Icatibant (acetate) (Synonyms: HOE 140) |
Catalog No.GC43888 |
Icatibant(아세테이트)(HOE-140 아세테이트)는 IC50 및 Ki가 각각 1.07nM 및 0.798nM인 브래디키닌 B2 수용체의 강력하고 특이적인 펩티드 길항제입니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 138614-30-9
Sample solution is provided at 25 µL, 10mM.
Icatibant is a synthetic peptide antagonist of the bradykinin B2 receptor with IC50 and Ki values of 1.07 and 0.798 nM, respectively, in guinea pig ileal cell membranes. It inhibits bradykinin-induced contractions in isolated guinea pig ileum and pulmonary arteries as well as in rat uterus (IC50s = 11, 5.4, and 4.9 nM, respectively). In vivo, icatibant inhibits bronchoconstriction induced by bradykinin in a guinea pig model (ID50s = 13.4 and 31.8 pmol/kg, i.v., for pulmonary resistance and dynamic lung compliance, respectively). Icatibant (30 µg, i.v.) also reduces vascular permeability in the footpad and intestine in a mouse model of hereditary angioedema. Formulations containing icatibant have been used for the treatment of hereditary angioedema.
Average Rating: 5
(Based on Reviews and 22 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *